123 related articles for article (PubMed ID: 24977737)
1. Malassezia pachydermatis fungaemia in an adult on posaconazole prophylaxis for acute myeloid leukaemia.
Choudhury S; Marte RL
Pathology; 2014 Aug; 46(5):466-7. PubMed ID: 24977737
[No Abstract] [Full Text] [Related]
2. No difference between posaconazole and fluconazole antifungal prophylaxis and mycological diagnostics except costs in patients undergoing AML chemotherapy: a 1-year "real-life" evaluation.
Bertz H; Drognitz K; Lübbert M
Ann Hematol; 2014 Jan; 93(1):165-7. PubMed ID: 23949313
[No Abstract] [Full Text] [Related]
3. Posaconazole prophylaxis in hematologic cancer.
van Nieuwkoop C; van Dissel JT
N Engl J Med; 2007 May; 356(21):2215; author reply 2215-8. PubMed ID: 17526089
[No Abstract] [Full Text] [Related]
4. Pharmacoeconomic evaluation of fluconazole, posaconazole and voriconazole for antifungal prophylaxis in patients with acute myeloid leukaemia undergoing first consolidation chemotherapy.
Heng SC; Slavin MA; Al-Badriyeh D; Kirsa S; Seymour JF; Grigg A; Thursky K; Bajel A; Nation RL; Kong DC
J Antimicrob Chemother; 2013 Jul; 68(7):1669-78. PubMed ID: 23485723
[TBL] [Abstract][Full Text] [Related]
5. Pharmacoeconomic evaluation of voriconazole versus posaconazole for antifungal prophylaxis in acute myeloid leukaemia.
Al-Badriyeh D; Slavin M; Liew D; Thursky K; Downey M; Grigg A; Bajel A; Stewart K; Kong DC
J Antimicrob Chemother; 2010 May; 65(5):1052-61. PubMed ID: 20237074
[TBL] [Abstract][Full Text] [Related]
6. A post-marketing evaluation of posaconazole plasma concentrations in neutropenic patients with haematological malignancy receiving posaconazole prophylaxis.
Bryant AM; Slain D; Cumpston A; Craig M
Int J Antimicrob Agents; 2011 Mar; 37(3):266-9. PubMed ID: 21236645
[TBL] [Abstract][Full Text] [Related]
7. Prevention of invasive fungal infections in patients with acute myeloid leukaemia: results of a single centre retrospective observational study with the use of posaconazole versus conventional mould-active azoles.
Dellacasa CM; Busca A; Audisio E; Marmont F; Barbui AM; Falda M; De Rosa FG; Frairia C; Allione B; D'Ardia S; Aydin S; Pecoraro C; Manetta S; Vitolo U
J Chemother; 2014 Oct; 26(5):315-20. PubMed ID: 24075616
[No Abstract] [Full Text] [Related]
8. Clinical effectiveness of posaconazole prophylaxis in patients with acute myelogenous leukaemia (AML): a 6 year experience of the Cologne AML cohort.
Vehreschild JJ; Rüping MJ; Wisplinghoff H; Farowski F; Steinbach A; Sims R; Stollorz A; Kreuzer KA; Hallek M; Bangard C; Cornely OA
J Antimicrob Chemother; 2010 Jul; 65(7):1466-71. PubMed ID: 20410061
[TBL] [Abstract][Full Text] [Related]
9. Treatment cost development of patients undergoing remission induction chemotherapy: a pharmacoeconomic analysis before and after introduction of posaconazole prophylaxis.
Heimann SM; Cornely OA; Vehreschild MJ; Glossmann J; Kochanek M; Kreuzer KA; Hallek M; Vehreschild JJ
Mycoses; 2014 Feb; 57(2):90-7. PubMed ID: 23790060
[TBL] [Abstract][Full Text] [Related]
10. Cost effectiveness of posaconazole in the prophylaxis of invasive fungal infections in acute leukaemia patients for the French healthcare system.
Michallet M; Gangneux JP; Lafuma A; Herbrecht R; Ribaud P; Caillot D; Dupont B; Moreau P; Berger P; O'Sullivan AK
J Med Econ; 2011; 14(1):28-35. PubMed ID: 21175376
[TBL] [Abstract][Full Text] [Related]
11. Antifungal Prophylaxis With Posaconazole Is Effective in Preventing Invasive Fungal Infections in Acute Myeloid Leukemia Patients During Induction and Salvage Chemotherapy.
Wong GC; Abdul Halim NA; Tan BH
Clin Infect Dis; 2015 Oct; 61(8):1351-2. PubMed ID: 26139846
[No Abstract] [Full Text] [Related]
12. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.
Cornely OA; Maertens J; Winston DJ; Perfect J; Ullmann AJ; Walsh TJ; Helfgott D; Holowiecki J; Stockelberg D; Goh YT; Petrini M; Hardalo C; Suresh R; Angulo-Gonzalez D
N Engl J Med; 2007 Jan; 356(4):348-59. PubMed ID: 17251531
[TBL] [Abstract][Full Text] [Related]
13. Posaconazole prophylaxis--impact on incidence of invasive fungal disease and antifungal treatment in haematological patients.
Peterson L; Ostermann J; Rieger H; Ostermann H; Rieger CT
Mycoses; 2013 Nov; 56(6):651-8. PubMed ID: 23710592
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics of posaconazole in neutropenic patients receiving chemotherapy for acute myelogenous leukemia or myelodysplastic syndrome.
AbuTarif MA; Krishna G; Statkevich P
Curr Med Res Opin; 2010 Feb; 26(2):397-405. PubMed ID: 20001450
[TBL] [Abstract][Full Text] [Related]
15. Posaconazole prophylaxis in hematologic cancer.
Weiler S; Bellmann R
N Engl J Med; 2007 May; 356(21):2214; author reply 2215-8. PubMed ID: 17522407
[No Abstract] [Full Text] [Related]
16. Efficacy of anti-fungal but not anti-bacterial prophylaxis in intensive primary AML therapy: a real-world, retrospective comparative single-centre study.
Gerber B; Köppel J; Paul M; Nguyen-Kim TD; Frauenfelder T; Nair G; Schanz U; Manz MG
Swiss Med Wkly; 2014; 144():w13985. PubMed ID: 25055166
[TBL] [Abstract][Full Text] [Related]
17. Antifungal prophylaxis in newly diagnosed AML patients-Adherence to guidelines and feasibility in a real life setting.
Berking S; Doedens D; Horns H; Fiegl M; Ostermann H; Rieger CT
Mycoses; 2017 Sep; 60(9):600-606. PubMed ID: 28504318
[TBL] [Abstract][Full Text] [Related]
18. Acremonium strictum fungaemia in a paediatric immunocompromised patient: diagnosis and treatment difficulties.
Hitoto H; Pihet M; Weil B; Chabasse D; Bouchara JP; Rachieru-Sourisseau P
Mycopathologia; 2010 Sep; 170(3):161-4. PubMed ID: 20340045
[TBL] [Abstract][Full Text] [Related]
19. Fatal disseminated infection due to Scedosporium prolificans in a patient with acute myeloid leukemia and posaconazole prophylaxis.
Rivier A; Perny J; Debourgogne A; Thivillier C; Lévy B; Gérard A; Machouart M
Leuk Lymphoma; 2011 Aug; 52(8):1607-10. PubMed ID: 21649548
[No Abstract] [Full Text] [Related]
20. Salvage therapy of refractory chronic disseminated candidiasis in a patient with acute myeloid leukaemia and secondary prophylaxis during allogeneic stem cell transplantation.
Vehreschild JJ; Krüger K; Kurzai O; Wickenhauser C; Behringer K; Töx U; Cornely OA
Mycoses; 2006; 49 Suppl 1():42-7. PubMed ID: 16961582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]